High-Altitude-Induced alterations in Gut-Immune Axis: A review

International Reviews of Immunology

Volumn 37, Issue 2, 2018, Pages 119-126

  Khanna, Kunjan ^a   Mishra, K P ^a   Ganju, Lilly ^a   Kumar, Bhuvnesh ^a   Singh, Shashi Bala ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Cytokines; gut; high altitude; inflammation; Peyer's patches; sIgA

Indexed keywords

IMMUNOMODULATING AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; CYTOKINE; IMMUNOGLOBULIN A;

ALTITUDE; ALTITUDE DISEASE; DYSBIOSIS; ENTEROPATHY; EXERCISE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; IMMUNOPATHOLOGY; INJURY; INTESTINAL BLEEDING; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MUCOSA INFLAMMATION; MUCOSAL DISEASE; MUCOSAL IMMUNITY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; REVIEW; ACCLIMATIZATION; ANTIBODY PRODUCTION; HYPOXIA; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUNTAINEERING; NATURAL KILLER CELL; PEYER PATCH;

ACCLIMATIZATION; ALTITUDE; ANTIBODY FORMATION; CYTOKINES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYPOXIA; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; KILLER CELLS, NATURAL; MOUNTAINEERING; PEYER'S PATCHES;

EID: 85042021317     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830185.2017.1407763     Document Type: Review

References (63)

1. Wu TY, Ding SQ, Liu JL, et al. High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula. World J Gastroenterol. 2007; 13(5): 774– 80. doi: 10.3748/wjg.v13.i5.774.
2. Hamad N, Travis S., Gastrointestinal Function. In: Swenson E., Bürtsch P., (eds). High Altitude. New York, NY: Springer; 2013; 2014: 253– 270. doi: https://doi.org/ 10.1007/978-1-4614-8772-2_13.
3. Anand AC, Sashindran VK, Mohan L. Gastrointestinal problems at high altitude. Trop Gastroenterol. 2006; 27(4): 147– 53.
4. Meehan R, Duncan U, Neale L, et al. Operation Everest II: alterations in the immune system at high altitudes. J Clin Immunol. 1988; 8(5): 397– 406. doi: 10.1007/BF00917156.
5. Rohm I, Aderhold N, Ratka J, et al. Hypobaric hypoxia in 3000 m altitude leads to a significant decrease in circulating plasmacytoid dendritic cells in humans. Clin Hemorheol Microcirc. 2016; 63(3): 257– 65. doi: 10.3233/CH-152035.
6. Chohan IS, Singh I, Balakrishnan K, Talwar GP. Immune response in human subjects at high altitude. Int J Biometeorol. 1975; 19(3): 137– 43. doi: 10.1007/BF01460012.
7. Facco M, Zilli C, Siviero M, et al. Modulation of immune response by the acute and chronic exposure to high altitude. Med Sci Sports Exerc. 2005; 37(5): 768– 74. doi: 10.1249/01.MSS.0000162688.54089.CE.
8. Liu B, Chen J, Zhang L, et al. IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis. Front Immunol. 2017; 8: 628. doi: 10.3389/fimmu.2017.00628.
9. Tiollier E, Schmitt L, Burnat P, et al. Living high-training low altitude training: effects on mucosal immunity. Eur J Appl Physiol. 2005; 94(3): 298– 304. doi: 10.1007/s00421-005-1317-4.
10. Zhang F, Deng Z, Li W, et al. Activation of autophagy in rats with plateau stress-induced intestinal failure. Int J Clin Exp Pathol. 2015; 8(2): 1816.
11. Svendsen IS, Hem E, Gleeson M. Effect of acute exercise and hypoxia on markers of systemic and mucosal immunity. Eur J Appl Physiol. 2016; 116(6): 1219– 29. doi: 10.1007/s00421-016-3380-4.
12. Kashyap R, Mahajan S, Sharma B, et al. A clinical profile of acute upper gastrointestinal bleeding at moderate altitude. J Indian Acad Clin Med. 2005; 6(3): 225.
13. Wu TY., Take note of altitude gastrointestinal bleeding. Newsletter Int Soc Mountain Med. 2001; 10: 9– 11.
14. Wu T, Liu J. Alcohol and aspirin in combination with dexamethasone causes gastrointestinal bleeding at high altitude. Wilderness Environ Med. 2006; 17(1): 69– 71. doi: 10.1580/1080-6032(2006)17%5b69:AAAICW%5d2.0.CO;2.
15. Li L, Zhao X. Comparative analyses of fecal microbiota in Tibetan and Chinese Han living at low or high altitude by barcoded 454 pyrosequencing. Sci Rep. 2015; 5: 14682. doi: 10.1038/srep14682.
16. Kleessen B, Schroedl W, Stueck M, et al. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Med Sci Sports Exerc. 2005; 37(8): 1313– 8. doi: 10.1249/01.mss.0000174888.22930.e0.
17. Adak A, Ghosh, Mondal KC. Modulation of small intestinal homeostasis along with its microflora during acclimatization at simulated hypobaric hypoxia. Indian J Exp Biol. 2014; 52(11): 1098– 105.
18. Adak A, Maity C, Ghosh K, Mondal KC. Alteration of predominant gastrointestinal flora and oxidative damage of large intestine under simulated hypobaric hypoxia. Z Gastroenterol. 2014; 52(2): 180– 6. doi: 10.1055/s-0033-1336007.
19. Li K, Gesang L, Dan Z, Gusang L. Genome-wide transcriptional analysis reveals the protection against hypoxia-induced oxidative injury in the intestine of Tibetans via the inhibition of GRB2/EGFR/PTPN11 pathways. Oxid Med Cell Longev. 2016; 2016: 6967396. doi: 10.1155/2016/6967396.
20. Zhang F, Wu W, Deng Z, et al. High altitude increases the expression of hypoxia-inducible factor 1α and inducible nitric oxide synthase with intestinal mucosal barrier failure in rats. Int J Clin Exp Pathol. 2015; 8(5): 5189– 95.
21. Luo H, Zhou DJ, Chen Z, et al. Establishment and evaluation of an experimental rat model for high-altitude intestinal barrier injury. Exp Ther Med. 2017; 13(2): 475– 482. doi: 10.3892/etm.2016.4012.
22. Solis de los Santos F, Farnell MB, Téllez G, et al. Effect of prebiotic on gut development and ascites incidence of broilers reared in a hypoxic environment. Poult Sci. 2005; 84(7): 1092– 100. doi: 10.1093/ps/84.7.1092.
23. Bletz MC, Loudon AH, Becker MH, et al. Mitigating amphibian chytridiomycosis with bioaugmentation: characteristics of effective probiotics and strategies for their selection and use. Ecol Lett. 2013; 16(6): 807– 20. doi: 10.1111/ele.12099.
24. Wu TY, Ding SQ, Liu JL, et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol. 2007; 8(2): 88– 107. doi: 10.1089/ham.2007.1015.
25. Basnyat B, Cumbo TA, Edelman R. Infections at high altitude. Clin Infect Dis. 2001; 33(11): 1887– 91. doi: 10.1086/324163.
26. Wen D, Zhang N, Shan B, Wang S. Helicobacter pylori infection may be implicated in the topography and geographic variation of upper gastrointestinal cancers in the Taihang Mountain high-risk region in northern China. Helicobacter. 2010; 15(5): 416– 21. doi: 10.1111/j.1523-5378.2010.00790.x.
27. Kleessen B, Schroedl W, Stueck M, et al. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Medicine & Science in Sports & Exercise. 2005; 37(8): 1313– 8. doi: 10.1249/01.mss.0000174888.22930.e0.
28. Xu CL, Sun R, Qiao XJ, et al. Protective effect of glutamine on intestinal injury and bacterial community in rats exposed to hypobaric hypoxia environment. World J Gastroenterol. 2014; 20(16): 4662– 74. doi: 10.3748/wjg.v20.i16.4662.
29. Li L, Wang H, Zhao X. Effects of Rhodiola on production, health and gut development of broilers reared at high altitude in Tibet. Sci Rep. 2014; 4: 7166. doi: 10.1038/srep07166.
30. Zhou QQ, Yang DZ, Luo YJ, et al. Over-starvation aggravates intestinal injury and promotes bacterial and endotoxin translocation under high-altitude hypoxic environment. World J Gastroenterol. 2011; 17(12): 1584– 93. doi: 10.3748/wjg.v17.i12.1584.
31. Luo H, Guo P, Zhou Q. Role of TLR4/NF-κB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia. PLoS One. 2012; 7(10): e46291. doi: 10.1371/journal.pone.0046291.
32. Dong Y, Zheng J, Wang XY, Zhou J. [Effect of oxygen therapy for injury of intestinal mucosal barrier of rabbits in high altitude hemorrhagic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005; 17(1): 32– 5.
33. Xu C, Sun R, Qiao X, et al. Effect of vitamin e supplementation on intestinal barrier function in rats exposed to high altitude hypoxia environment. Korean J Physiol Pharmacol. 2014; 18(4): 313– 20. doi: 10.4196/kjpp.2014.18.4.313.
34. Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis. 2010; 52(6): 467– 84. doi: 10.1016/j.pcad.2010.02.003.
35. Taylor AT. High-altitude illnesses: physiology, risk factors, prevention, and treatment. Rambam Maimonides Med J. 2011; 2(1): e0022. doi: 10.5041/RMMJ.10022.
36. Carod-Artal FJ., High-altitude headache and acute mountain sickness. Neurologia. 2014; 29(9): 533– 40. doi: 10.1016/j.nrl.2012.04.015.
37. Janeway CA, Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th ed. New York: Garland Science; 2001.
38. Sminia T, van der Brugge-Gamelkoorn GJ, Jeurissen SH. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol. 1989; 9(2): 119– 50.
39. Jung C, Hugot JP, Barreau F. Peyer's patches: the immune sensors of the intestine. Int J Inflam. 2010; 2010: 823710. doi: 10.4061/2010/823710.
40. Jang MH, Kweon MN, Iwatani K, et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A. 2004; 101(16): 6110– 5. doi: 10.1073/pnas.0400969101.
41. Corr SC, Gahan CC, Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol. 2008; 52(1): 2– 12. doi: 10.1111/j.1574-695X.2007.00359.x.
42. Singh B, Maharjan S, Jiang T, et al. Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine. Mol Pharm. 2015; 12(11): 3816– 28. doi: 10.1021/acs.molpharmaceut.5b00265.
43. Kim SH, Lee KY, Jang YS. Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination. Immune Netw. 2012; 12(5): 165– 75. doi: 10.4110/in.2012.12.5.165.
44. Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog. 2010; 6(11): e1001147. doi: 10.1371/journal.ppat.1001147.
45. Yamamoto M, Pascual DW, Kiyono H. M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol. 2012; 354: 39– 52.
46. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009; 124(1): 3– 20; quiz 21–2. doi: 10.1016/j.jaci.2009.05.038.
47. Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012; 24(6): 503– 12. doi: 10.1111/j.1365-2982.2012.01921.x.
48. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013; 6(4): 295– 308. doi: 10.1177/1756283X13482996.
49. Grajek W, Olejnik A, Sip A. Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim Pol. 2005; 52(3): 665– 71.
50. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug discovery today. 2003; 8(15): 692– 700. doi: 10.1016/S1359-6446(03)02746-6.
51. Basnyat B. High altitude pilgrimage medicine. High Alt Med Biol. 2014; 15(4): 434– 439. doi: 10.1089/ham.2014.1088.
52. Khajali F, Moghaddam MH, Hassanpour H. An L-arginine supplement improves broiler hypertensive response and gut function in broiler chickens reared at high altitude. Int J Biometeorol. 2014; 58(6): 1175– 9. doi: 10.1007/s00484-013-0710-7.
53. De Greef E, Vandenplas Y, Hauser B, et al. Probiotics and IBD. Acta Gastroenterol Belg. 2013; 76(1): 15– 9.
54. Caris AV, Da Silva ET, Dos Santos SA, Tufik S, Dos Santos RVT. Effects of carbohydrate and glutamine supplementation on oral mucosa immunity after strenuous exercise at high altitude: a double-blind randomized trial. Nutrients. 2017 Jul 3; 9(7). pii: E692. doi: 10.3390/nu9070692.
55. Van Rooij P, Martel A, Haesebrouck F, Pasmans F. Amphibian chytridiomycosis: a review with focus on fungus-host interactions. Vet Res. 2015 Nov 25; 46: 137. doi: 10.1186/s13567-015-0266-0.
56. Kriger KM, HERO J. Altitudinal distribution of chytrid (Batrachochytrium dendrobatidis) infection in subtropical Australian frogs. Austral Ecology. 2008 Dec 1; 33(8): 1022– 32. doi: 10.1111/j.1442-9993.2008.01872.x.
57. Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol. 2015 Nov 15; 195(10): 4999– 5010. doi: 10.4049/jimmunol.1402598.
58. Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013 Feb 28; 182(2): 375– 87. doi: 10.1016/j.ajpath.2012.10.014.
59. Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A. Intestinal permeability in a patient with liver cirrhosis. Ther Clin Risk Manag. 2016 Nov 18; 12: 1729– 1748. doi: 10.2147/TCRM.S115902.
60. DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016 May; 22(5): 1137– 50. doi: 10.1097/MIB.0000000000000750.
61. Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol. 2017 Jun 14; 23(22): 3954– 3963. doi: 10.3748/wjg.v23.i22.3954.
62. Yadav AP, Mishra KP, Ganju L, Singh SB. Wintering in Antarctica: impact on immune response of Indian expeditioners. Neuroimmunomodulation. 2012; 19(6): 327– 33. doi: 10.1159/000339512.
63. Mishra KP, Yadav AP, Shweta, Chanda S, Majumdar D, Ganju L. Serum levels of immunoglobulins (IgG, IgA, IgM) in Antarctic summer expeditioners and their relationship with seasickness. Cell Immunol. 2011; 271(1): 29– 35. doi: 10.1016/j.cellimm.2011.05.018.